INTEROMEX BIOPHARMACEUTICALS

Interomex Biopharmaceuticals Inc. is dedicated to the identification of novel biological targets in key cellular processes with the aim of discovering lead compounds for the treatment of disease. The company’s proprietary Repressed Trans-activator (RTATM) technology can be used to detect protein-protein interactions between a host and an infectious agent, as well as within cells in normal and diseased states. A particular advantage of RTATM is its ability to detect the interactions of transcription transactivator proteins, which are key control points in viral infections and cell activation.

#Financial #Website #More

INTEROMEX BIOPHARMACEUTICALS

Industry:

Biopharma Biotechnology Medical

Founded:

1999-01-01

Address:

Vancouver, British Columbia, Canada

Country:

Canada

Website Url:

http://www.interomex.com

Total Employee:

1+

Status:

Closed

Total Funding:

4 M USD

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible Google Analytics Apple Mobile Web Clips Icon Content Delivery Network Google Universal Analytics Font Awesome Nginx Amazon IPv6

Investors List

business-development-bank-of-canada_image

Business Development Bank of Canada

Business Development Bank of Canada investment in Series B - Interomex BioPharmaceuticals

genechem_image

GeneChem

GeneChem investment in Series B - Interomex BioPharmaceuticals

t2c2-capital_image

T2C2 Capital

T2C2 Capital investment in Series B - Interomex BioPharmaceuticals

ventures-west_image

Ventures West

Ventures West investment in Series B - Interomex BioPharmaceuticals

Official Site Inspections

http://www.interomex.com

Host Informations
Whois Informations

Loading ...

More informations about "Interomex BioPharmaceuticals" on Search Engine